维持性血液透析合并难治性继发性甲状旁腺功能亢进患者甲状旁腺激素水平与骨密度的关系
收稿日期: 2020-10-21
网络出版日期: 2022-07-26
占志朋, 谢席胜, 张凌 . 维持性血液透析合并难治性继发性甲状旁腺功能亢进患者甲状旁腺激素水平与骨密度的关系[J]. 内科理论与实践, 2021 , 16(01) : 45 -48 . DOI: 10.16138/j.1673-6087.2021.01.010
| [1] | Cozzolino M, Shilov E, Li Z, et al. Pattern of laboratory parameters and management of secondary hyperparathyroidism in countries of Europe, Asia, the Middle East, and North America[J]. Adv Ther, 2020, 37(6): 2748-2762. |
| [2] | Wang J, Bieber BA, Hou FF, et al. Mineral and bone disorder and management in the China dialysis outcomes and practice patterns study[J]. Chin Med J (Engl), 2019, 132(23): 2775-2782. |
| [3] | Pimentel A, Ureña-Torres P, Zillikens MC, et al. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of nephrology dialysis and transplantation[J]. Kidney Int, 2017, 92(6): 1343-1355. |
| [4] | Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) guideline update: what’s changed and why it matters[J]. Kidney Int, 2017, 92(1): 26-36. |
| [5] | West SL, Lok CE, Langsetmo L, et al. Bone mineral density predicts fractures in chronic kidney disease[J]. J Bone Miner Res, 2015, 30(5): 913-919. |
| [6] | Leder BZ. Parathyroid hormone and parathyroid hormone-related protein analogs in osteoporosis therapy[J]. Curr Osteoporos Rep, 2017, 15(2): 110-119. |
| [7] | Iimori S, Mori Y, Akita W, et al. Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients-a single-center cohort study[J]. Nephrol Dial Transplant, 2012, 27(1): 345-351. |
| [8] | Kumar R, Thompson JR. The regulation of parathyroid hormone secretion and synthesis[J]. J Am Soc Nephrol, 2011, 22(2): 216-224. |
| [9] | Wojda SJ, Donahue SW. Parathyroid hormone for bone regeneration[J]. J Orthop Res, 2018, 36(10): 2586-2594. |
| [10] | Murray TM, Rao LG, Divieti P, et al. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands[J]. Endocr Rev, 2005, 26(1): 78-113. |
| [11] | Malluche HH, Davenport DL, Cantor T, et al. Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis[J]. Clin J Am Soc Nephrol, 2014, 9(7): 1254-1262. |
| [12] | Huang GS, Chu TS, Lou MF, et al. Factors associated with low bone mass in the hemodialysis patients-a cross-sectional correlation study[J]. BMC Musculoskelet Disord, 2009, 10: 60. |
| [13] | Jerome CP, Burr DB, Van Bibber T, et al. Treatment with human parathyroid hormone(1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis)[J]. Bone, 2001, 28(2): 150-159. |
| [14] | Lau WL, Obi Y, Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism[J]. Clin J Am Soc Nephrol, 2018, 13(6): 952-961. |
| [15] | 郑淑蓓, 郑育, 李占园, 等. 成纤维细胞生长因子23、Klotho蛋白与血液透析患者骨密度改变的关系[J]. 中华肾脏病杂志, 2016, 32(5): 321-326. |
| [16] | Chu X, Zhu Y, Wang O, et al. Bone mineral density and its serial changes are associated with PTH levels in pseudohypoparathyroidism type 1B patients[J]. J Bone Miner Res, 2018, 33(4): 743-752. |
| [17] | Gao C, Qiao J, Li SS, et al. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China[J]. Osteoporos Int, 2017, 28(1): 211-218. |
| [18] | Kazama JJ, Wakasugi M. Parathyroid hormone and bone in dialysis patients[J]. Ther Apher Dial, 2018, 22(3): 229-235. |
/
| 〈 |
|
〉 |
